{"id":"https://openalex.org/W2418829344","doi":null,"title":"Dabigatran: rational dose individualisation and monitoring guidance is needed.","display_name":"Dabigatran: rational dose individualisation and monitoring guidance is needed.","publication_year":2012,"publication_date":"2012-06-29","ids":{"openalex":"https://openalex.org/W2418829344","mag":"2418829344","pmid":"https://pubmed.ncbi.nlm.nih.gov/22854367"},"language":"en","primary_location":{"id":"pmid:22854367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22854367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New Zealand medical journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028396452","display_name":"Stephen Brent Duffull","orcid":"https://orcid.org/0000-0002-6545-9408","observed_orcids":["https://orcid.org/0000-0002-6545-9408"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Stephen B Duffull","raw_affiliation_strings":["School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand. stephen.duffull@otago.ac.nz","School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand. stephen.duffull@otago.ac.nz","institution_ids":["https://openalex.org/I80281795"]},{"raw_affiliation_string":"School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068008476","display_name":"Daniel F. B. Wright","orcid":"https://orcid.org/0000-0001-9313-9252","observed_orcids":["https://orcid.org/0000-0001-9313-9252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel F B Wright","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037033929","display_name":"Hesham Saleh Al-Sallami","orcid":"https://orcid.org/0000-0002-0685-327X","observed_orcids":["https://orcid.org/0000-0002-0685-327X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hesham S Al-Sallami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063724683","display_name":"Paul Jacques Zufferey","orcid":"https://orcid.org/0000-0003-2899-1195","observed_orcids":["https://orcid.org/0000-0003-2899-1195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J Zufferey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111945259","display_name":"James M. Faed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M Faed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2701,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.89822115,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"125","issue":"1357","first_page":"148","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dabigatran","display_name":"dabigatran","score":1.0},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.8610000014305115},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.8960000276565552},{"id":"https://openalex.org/keywords/anticoagulation-monitoring","display_name":"anticoagulation monitoring","score":0.9459999799728394},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-prescribing","display_name":"drug prescribing","score":0.3370000123977661},{"id":"https://openalex.org/keywords/rational-therapeutics","display_name":"rational therapeutics","score":0.7519999742507935},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.9694903492927551},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9011574983596802},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6790533661842346},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6185169219970703},{"id":"https://openalex.org/C2776654903","wikidata":"https://www.wikidata.org/wiki/Q2601463","display_name":"SAFER","level":2,"score":0.5581247210502625},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.51767897605896},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42360636591911316},{"id":"https://openalex.org/C2992750412","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Oral anticoagulant","level":4,"score":0.4208866357803345},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.3533743619918823},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.340615838766098},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.33489757776260376},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24862879514694214},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.07852402329444885},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069604","descriptor_name":"Dabigatran","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009520","descriptor_name":"New Zealand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015091","descriptor_name":"beta-Alanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015091","descriptor_name":"beta-Alanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22854367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22854367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New Zealand medical journal","raw_type":"Journal Article"},{"id":"mag:2418829344","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22854367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1643902638","https://openalex.org/W4252948123","https://openalex.org/W2024273003","https://openalex.org/W1602883505","https://openalex.org/W2320687132","https://openalex.org/W2370497369","https://openalex.org/W2782557684","https://openalex.org/W7015602892","https://openalex.org/W2242598720","https://openalex.org/W7209390251"],"abstract_inverted_index":{"Dabigatran":[0],"is":[1,59,75,104],"the":[2,21,37,77,93,109,138],"first":[3],"oral":[4],"anticoagulant":[5],"to":[6,44,89,132],"be":[7,45,65,81,165],"introduced":[8],"in":[9,67,149],"New":[10],"Zealand":[11],"without":[12],"prescribing":[13,142],"restrictions":[14],"for":[15,114,170,177],"over":[16],"50":[17],"years.":[18],"Not":[19],"surprisingly,":[20],"drug":[22,62,79],"has":[23],"created":[24],"a":[25,46,105,168,175],"great":[26],"deal":[27],"of":[28,69,92,111,143],"interest":[29],"amongst":[30],"health":[31],"care":[32],"providers":[33],"as":[34,36,85,87,167,174],"well":[35,86],"general":[38,47],"public":[39],"and":[40,56,63,83,117,140,158],"media.":[41],"There":[42],"seems":[43],"feeling":[48],"that":[49,76,102,137],"warfarin,":[50],"with":[51,96,108],"its":[52],"requisite":[53],"dose":[54,156],"adjustments":[55],"INR":[57],"monitoring,":[58],"an":[60],"outdated":[61],"should":[64,163],"shelved":[66],"favour":[68],"this":[70,99,122],"novel":[71],"agent.":[72],"The":[73],"assumption":[74],"newer":[78],"must":[80],"better":[82],"safer":[84],"easier":[88],"use.":[90],"Much":[91],"literature":[94],"associated":[95],"dabigatran":[97,103,127,171],"encourages":[98],"view,":[100],"stressing":[101],"'game":[106],"changer'":[107],"advantage":[110],"fixed":[112],"dosing":[113],"most":[115,153],"patients":[116],"no":[118],"anticoagulation":[119],"monitoring.":[120,160],"In":[121],"paper":[123],"we":[124],"question":[125],"whether":[126],"can":[128],"really":[129],"live":[130],"up":[131],"these":[133],"expectations.":[134],"We":[135],"suggest":[136],"safe":[139],"effective":[141],"dabigatran,":[144],"like":[145],"all":[146],"anticoagulants":[147],"used":[148],"therapeutic":[150],"doses,":[151],"will":[152],"likely":[154],"require":[155],"individualisation":[157],"selective":[159],"This":[161],"requirement":[162],"not":[164],"viewed":[166],"failure":[169],"but":[172],"rather":[173],"success":[176],"rational":[178],"therapeutics.":[179]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}